DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Eden vs MEDVi: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Eden prints a comparable month-to-month price, $129 a month; MEDVi’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only Eden prints a comparable month-to-month price, $99 a month; MEDVi’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Eden and MEDVi, measure by measure

Eden and MEDVi side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureEdenMEDVi
Tirzepatide, month to month$129 (per month)—
Tirzepatide, lowest printed$129 (every month)—
Semaglutide, month to month$99 (per month)—
Semaglutide, lowest printed$99 (every month)—
Dose pricingsame price at every dosenot confirmed
Membership or program feenonenot confirmed
Computed score34.3 of 40 (position 3 of 27)0 of 40 (position 21 of 27)
FDA warning letters728279 (2026-06-08)721455 (2026-02-20)
November 20 readfirst-party readnot readable Nov 20

Strengths and limitations: which fits whom

Eden prints one price at every dose with no membership, so a dose increase does not change the bill. MEDVi cannot be judged on price this month because its page could not be read on November 20, 2026. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Edentirzepatide$408$129
Edensemaglutide$198$99

Regulatory record

FDA’s warning-letter index lists warning letter 728279 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to Eden; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding. FDA’s warning-letter index lists warning letter 721455 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to MEDVi; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Eden’s current prices ↗
Check MEDVi’s current prices ↗

Frequently asked

Which is cheaper, Eden or MEDVi?

On compounded tirzepatide, only Eden prints a comparable month-to-month price, $129 a month; MEDVi’s page could not be read on November 20, 2026, so no like-for-like comparison is possible. On compounded semaglutide, only Eden prints a comparable month-to-month price, $99 a month; MEDVi’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Do Eden and MEDVi charge a membership fee?

Eden: no membership fee; MEDVi: not confirmed on November 20, 2026. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Eden and MEDVi medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Eden recordEden alternativesMEDVi recordMEDVi alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.